DRUG PRICING REFORM MAY LOWER COSTS, BUT PAYMENT PREVENTION DELIVERS IMMEDIATE SAVINGS

Drug pricing reform is a common Medicaid cost-containment strategy. Policymakers continue exploring expanded rebates, alternative purchasing models, and other approaches designed to reduce pharmacy spending and ease pressure on state budgets.

Lower drug prices can generate meaningful savings. However, they address only part of Medicaid’s financial challenge.

Many of Medicaid’s largest sources of avoidable spending have little to do with the cost of healthcare services. Instead, they result from payment decisions being made with incomplete eligibility information, unknown commercial coverage, or missing third-party liability (TPL) data.

A claim paid incorrectly remains an improper payment, even if the service was purchased at a discounted price.

THE REAL COST DRIVER NOBODY TALKS ABOUT

Much of the Medicaid cost-containment conversation focuses on reducing the cost of care. An equally important question is whether Medicaid should have paid the claim at all.

Every day, Medicaid processes millions of claims while coverage information continues to change. Beneficiaries gain employer-sponsored insurance, add dependent coverage, move between programs, and experience eligibility changes throughout the year.

The challenge is not that coverage changes occur. The challenge is that Medicaid systems often learn about those changes after claims have already been paid. Eligibility information may be weeks or months old.

During that delay, claims are adjudicated using incomplete coverage information, increasing the likelihood of improper payments and avoidable spending.

THE LACK OF QUALITY ELIGIBILITY DATA AND UNKNOWN TPL

One of the most persistent challenges facing Medicaid agencies and managed care organizations is identifying all available third-party coverage before claims are paid.

Commercial insurance can exist without appearing in Medicaid systems. Employer-sponsored coverage may become active before state databases are updated. Coverage identified at the point of service may never be reflected in Medicaid eligibility records. Delayed carrier reporting can create visibility gaps that last for weeks.

When coverage is unknown, Medicaid loses the ability to coordinate benefits effectively.

Claims that should have been billed to commercial insurance are instead paid by Medicaid because the necessary information was not available during adjudication.

This is why unknown coverage remains one of the most significant payment prevention challenges in Medicaid today.

WHY PREVENTION OUTPERFORMS RECOVERY

Post-payment recovery programs remain an important component of program integrity efforts. Recovering funds that should not have been paid is valuable and necessary.

However, recovery addresses problems only after the payment has already occurred.

By the time recovery efforts begin, Medicaid has already paid the claim, administrative resources have been consumed, and the original payment error has occurred.

More importantly, federal payment accuracy measurements evaluate whether claims were processed correctly at the time of adjudication. Recovering funds later does not change the original payment decision.

Preventing improper payments before they occur is more efficient than attempting to recover them afterward.

Every claim prevented is one less claim to recover.

Every coverage record identified before adjudication is one less opportunity for improper payment.

PAYMENT PREVENTION CAN GENERATE SAVINGS TODAY

Unlike many large-scale healthcare reforms that require lengthy implementation timelines, payment prevention initiatives and technologies can begin producing results immediately.

Improving eligibility verification, strengthening TPL identification efforts, leveraging more current coverage data, and enhancing coordination of benefits operations can help organizations:

• Reduce improper payments
• Improve payment accuracy
• Strengthen PERM performance
• Reduce recovery workloads
• Lower administrative costs
• Improve overall program integrity

These benefits are available today and do not depend on new legislation, federal demonstrations, or future policy changes.

MEDICAID NEEDS BOTH COST CONTROL AND PAYMENT ACCURACY

Drug pricing reform and payment prevention should not be viewed as competing strategies. Both play important roles in a comprehensive Medicaid cost-containment program.

Lower drug prices can reduce the cost of individual claims. Payment prevention reduces the number of claims Medicaid should not have paid in the first place.

The most successful Medicaid programs will pursue both approaches simultaneously: controlling healthcare costs while improving eligibility visibility, identifying third-party coverage sooner, and ensuring claims are directed to the appropriate payer before payment occurs.

Long-term program integrity requires more than negotiating lower prices. It requires making the right payment decision the first time.